Trial Tuesday: Idiopathic Pulmonary Fibrosis Waits On Its Groundhog Day
Manas Mishra
4 min read
members
Page 5 of 10
Milestone Monday: Count the Events, Not the Paperwork
Capsul Desk
5 min read
members
The Long View: Two Ways To Do A Deal
Mary Jo Laffler
6 min read
members
Therapeutic Thursday: A New Neighbourhood For mRNA
Aakash Babu
3 min read
members
Watchdog Wednesday: The Evolution Of EMA’s Real-World Evidence Policy
Nielsen Hobbs
6 min read
members
Trial Tuesday: The Slow Drift Out Of US Trials
The US still has the biggest market and the deepest regulatory expertise but early-stage sponsors are increasingly starting somewhere else.
Manas Mishra
4 min read
members
Milestone Monday: In This IPO Market, $81m Is The Small One
Capsul Desk
4 min read
members
The Long View: Sanofi Rebuilds Its Workforce Around AI, Just As It Gets Pickier About What Advances
The discovery engine now runs twice as fast. A new chief executive is culling late-stage assets and raising the Phase II bar, so the bet rides on whether faster also means better.
Capsul Desk
6 min read
members
Therapeutic Thursday: The Good, The Bad And The Ugly
Aakash Babu
5 min read
members
Watchdog Wednesday: How To Avoid Starring In A Harrison Ford Movie
The Tavneos withdrawal fight is a lesson in how little pre-signing diligence protects you, and how much your representations, covenants, and real-world evidence still can.
Nielsen Hobbs
8 min read
Trial Tuesday: The Number Arrowhead Wasn't Looking For
Twin trials erased acute pancreatitis in high-risk patients, and Arrowhead priced its drug just above Ionis's, not below. The full readout lands at ESC on Aug 30, where analysts settle the score.
Capsul Desk
4 min read
members
Milestone Monday: In Biopharma Venture Funding, The Middle Round Goes Missing
Three nine-figure private raises and a royalty deal worth up to $425m in a two-week run last month, with almost nothing in the $50m to $100m band between them and the seed stage. The companies that need that rung are learning to route around it.
Capsul Desk
4 min read
members